Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV Infection - Wikidata - wikimedia - TriplyDB

Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV Infection

Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV Infection

http://www.wikidata.org/entity/Q33668482

about

Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers.

P2860

Q47263592-2D4BC726-8922-4A53-8B50-9D1880DDFBB5

P2860

Plasma IP-10 Concentrations Correlate Positively with Viraemia and Inversely with CD4 Counts in Untreated HIV Infection

http://www.wikidata.org/entity/Q33668482

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Plasma IP-10 Concentrations Co ...... nts in Untreated HIV Infection

@ast

Plasma IP-10 Concentrations Co ...... nts in Untreated HIV Infection

@en

type

label

Plasma IP-10 Concentrations Co ...... nts in Untreated HIV Infection

@ast

Plasma IP-10 Concentrations Co ...... nts in Untreated HIV Infection

@en

prefLabel

Plasma IP-10 Concentrations Co ...... nts in Untreated HIV Infection

@ast

Plasma IP-10 Concentrations Co ...... nts in Untreated HIV Infection

@en

P1433

Q33668482-5321DE3F-6BA9-40AA-9658-8BA0106513B4

P1476

Q33668482-2202A070-98A9-482B-9FC7-F51775597155

P2093

Q33668482-07BC78E0-5D0A-4F0D-A3D2-0CE2FA94C7B5

Q33668482-3EE9D8B1-6016-4212-9CCC-30CF93DF9117

Q33668482-6B805766-EED6-4246-A330-BF62790D8026

Q33668482-745893C1-0E94-44D4-9417-6A740342AD11

Q33668482-836928BE-338F-44EA-8BC1-054DF158A859

Q33668482-91340326-5A34-4E3F-83D6-C90E7EE09A2E

Q33668482-D00A1ED6-E15F-4421-A53F-A3FF9BECE01B

Q33668482-DB399953-BE9C-4FE5-8FE7-7FB72395F261

Q33668482-E1189F67-6543-490C-AAD5-7BE61BDB6451

Q33668482-E6166DF3-6502-4DAB-8E5C-8E81E28CDD07

P2860

Q33668482-00CD53F0-7C55-4964-8AF3-534708321BED

Q33668482-03D127C5-06E8-44A4-B834-88ADBAB1013F

Q33668482-03E08927-7F9F-4E15-87FE-4C70ED89F558

Q33668482-03F9143E-4A3C-456D-A34E-024C3885CFC8

Q33668482-0B1A9FA3-F6F7-423A-A985-35087459B3D8

Q33668482-0BD7C1A2-7746-464E-806B-E765364A2100

Q33668482-13E07516-2686-40EC-A62F-DD5B87C79F53

Q33668482-1801D79D-E83F-4BB9-AF62-613981155210

Q33668482-29BAFF9F-199F-4883-ACCC-1E3BBEED66D0

Q33668482-31D5F722-ABB3-4E98-902E-18E14B2EA3E5

P304

Q33668482-044E5962-8A39-4F0E-BAA8-17DBC45F8DC7

P31

Q33668482-3265BF85-5FF2-45A6-801C-E89158541FFD

P356

Q33668482-8C08C3C7-6F1D-44DF-8230-2753C9121F40

P478

Q33668482-87358F00-411D-4475-AB7F-23FAE56721D4

P50

Q33668482-3BA26A01-1A2D-4787-9BA0-4ECD803AB759

P577

Q33668482-C343AA9C-3EED-42E1-8296-EACBBEE2EF2E

P698

Q33668482-A6FDF4F2-A024-4EFD-BA3B-8FC4D17FE7CE

P932

Q33668482-9779D7DD-7592-4D18-A328-2430E9DEDE57

P356

1874613601711010024

P1433

The open AIDS journal

P1476

Plasma IP-10 Concentrations Co ...... nts in Untreated HIV Infection

@en

P2093

Cuthbert Musarurwa

http://www.w3.org/2001/XMLSchema#string

Doreen Zvipo Mhandire

http://www.w3.org/2001/XMLSchema#string

Hilda Tendisa Matarira

http://www.w3.org/2001/XMLSchema#string

Kerina Duri

http://www.w3.org/2001/XMLSchema#string

Kudakwashe Mhandire

http://www.w3.org/2001/XMLSchema#string

Kudzaishe Mateveke

http://www.w3.org/2001/XMLSchema#string

Lovemore Ronald Mazengera

http://www.w3.org/2001/XMLSchema#string

Lynn Sodai Zijenah

http://www.w3.org/2001/XMLSchema#string

Mqondisi Tshabalala

http://www.w3.org/2001/XMLSchema#string

Petronella Taonga Wekare

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy

Immune activation and HIV persistence: considerations for novel therapeutic interventions.

Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton.

Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.

HIV-associated chronic immune activation.

Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?

Persistent immune activation in chronic HIV infection: do any interventions work?

P304

24-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874613601711010024

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Babill Stray-Pedersen

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28553429

http://www.w3.org/2001/XMLSchema#string

P932

5427702

http://www.w3.org/2001/XMLSchema#string